TrialBlood advances2026
RNA interference therapy targeting coagulation factor XI: a first-in-human trial of RBD4059 (vortosiran).
Anders Gabrielsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it